Filing Details
- Accession Number:
- 0000315066-17-002237
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-03 17:47:00
- Reporting Period:
- 2017-03-30
- Filing Date:
- 2017-04-03
- Accepted Time:
- 2017-04-03 17:47:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1597313 | Viewray Inc. | VRAY | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
315066 | Fmr Llc | 245 Summer Street Boston MA 02210 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-03-30 | 28,661 | $8.46 | 6,856,060 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
Footnotes
- By Impresa Fund III Limited Partnership (1,356,613 shares of Common Stock), F-Prime Capital Partners Healthcare Fund II LP (5,489,923), F-Prime Capital Partners Healthcare Advisors Fund II LP (1,646)and F-Prime Inc. (7,878 shares of Common Stock). The general partner of F-Prime Capital Partners Healthcare Fund II LP is F-Prime Capital Partners Healthcare Advisors Fund II LP. F-Prime Capital Partners Healthcare Advisors Fund II LP and Impresa Fund III Limited Partnership are each solely managed by Impresa Management LLC, their general partner and investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family. F-Prime Inc. is a wholly-owned subsidiary of FMR LLC.
- The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $8.39 to $8.54. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.